Haleon (HLN) Cash & Equivalents (2021 - 2026)
Haleon's (HLN) quarterly Cash & Equivalents came in at $1.1 billion in Q2 2026, down 37.53% on a QoQ basis from $1.8 billion in Q4 2025.
Haleon (HLN) Cash & Equivalents (2021 - 2026) Analysis & Trends
Haleon (HLN) has 6 years of Cash & Equivalents data on file, last reported at $1.1 billion in Q2 2026.
- Quarterly Cash & Equivalents changed N/A year-over-year to $1.1 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.1 billion (changed N/A YoY) and the FY2025 annual result came in at $1.8 billion, down 38.77% from the prior year.
- Cash & Equivalents eased to $1.1 billion in Q2 2026, from $1.8 billion in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $2.9 billion in Q4 2024 to a low of $613.2 million in Q2 2023.
- A 5-year average of $1.4 billion and a median of $1.2 billion in 2023 frame the typical range for Cash & Equivalents.
- Annual changes were most pronounced in 2023 — Cash & Equivalents slumped 63.5% — and 2024, when it surged 122.87%.
- Tracing HLN's Cash & Equivalents over 5 years: stood at $802.3 million in 2022, then jumped by 61.51% to $1.3 billion in 2023, then surged by 122.87% to $2.9 billion in 2024, then plunged by 38.57% to $1.8 billion in 2025, then plunged by 37.53% to $1.1 billion in 2026.
- The last three Cash & Equivalents figures came in at $1.1 billion (Q2 2026), $1.8 billion (Q4 2025), and $2.9 billion (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 1.48 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 2.89 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 1.80 Bn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 332.40 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 164.00 Mn |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | 511.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.11 Bn |
| Dec 31, 2025 | 1.77 Bn |
| Dec 31, 2024 | 2.89 Bn |
| Jun 30, 2024 | 670.24 Mn |
| Dec 31, 2023 | 1.30 Bn |
| Jun 30, 2023 | 613.17 Mn |
| Dec 31, 2022 | 802.28 Mn |
| Jun 30, 2022 | 1.68 Bn |
| Dec 31, 2021 | 558.08 Mn |